Literature DB >> 11923480

Knockout of PKC alpha enhances insulin signaling through PI3K.

Michael Leitges1, Markus Plomann, Mary L Standaert, Gautam Bandyopadhyay, Mini P Sajan, Yoshinori Kanoh, Robert V Farese, Michael Letiges.   

Abstract

Insulin stimulates glucose transport and certain other metabolic processes by activating atypical PKC isoforms (lambda, zeta, iota) and protein kinase B (PKB) through increases in D3-polyphosphoinositides derived from the action of PI3K. The role of diacylglycerol-sensitive PKC isoforms is less clear as they have been suggested to be both activated by insulin and yet inhibit insulin signaling to PI3K. Presently, we found that insulin signaling to insulin receptor substrate 1-dependent PI3K, PKB, and PKC lambda, and downstream processes, glucose transport and activation of ERK, were enhanced in skeletal muscles and adipocytes of mice in which the ubiquitous conventional diacylglycerol-sensitive PKC isoform, PKC alpha, was knocked out by homologous recombination. On the other hand, insulin provoked wortmannin-insensitive increases in immunoprecipitable PKC alpha activity in adipocytes and skeletal muscles of wild-type mice and rats. We conclude that 1) PKC alpha is not required for insulin-stimulated glucose transport, and 2) PKC alpha is activated by insulin at least partly independently of PI3K, and largely serves as a physiological feedback inhibitor of insulin signaling to the insulin receptor substrate 1/PI3K/PKB/PKC lambda/zeta/iota complex and dependent metabolic processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11923480     DOI: 10.1210/mend.16.4.0809

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  57 in total

1.  Altered morphology and function of the lacrimal functional unit in protein kinase C{alpha} knockout mice.

Authors:  Zhuo Chen; Zhijie Li; Surendra Basti; William J Farley; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

Review 2.  Specific protein kinase C isoforms as transducers and modulators of insulin signaling.

Authors:  Sanford R Sampson; Denise R Cooper
Journal:  Mol Genet Metab       Date:  2006-06-23       Impact factor: 4.797

3.  PRKCA: a positional candidate gene for body mass index and asthma.

Authors:  Amy Murphy; Kelan G Tantisira; Manuel E Soto-Quirós; Lydiana Avila; Barbara J Klanderman; Stephen Lake; Scott T Weiss; Juan C Celedón
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

4.  PKC alpha-dependent regulation of the IGF1 receptor in adult and embryonic rat cardiomyocytes.

Authors:  Ruchita Maniar; Anna Pecherskaya; Richard Ila; Michele Solem
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

5.  Calcium-dependent isoforms of protein kinase C mediate glycine-induced synaptic enhancement at the calyx of Held.

Authors:  YunXiang Chu; Diasynou Fioravante; Monica Thanawala; Michael Leitges; Wade G Regehr
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

Review 6.  Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice.

Authors:  M Meier; J Menne; H Haller
Journal:  Diabetologia       Date:  2009-02-24       Impact factor: 10.122

7.  PKCalpha regulates platelet granule secretion and thrombus formation in mice.

Authors:  Olga Konopatskaya; Karen Gilio; Matthew T Harper; Yan Zhao; Judith M E M Cosemans; Zubair A Karim; Sidney W Whiteheart; Jeffery D Molkentin; Paul Verkade; Steve P Watson; Johan W M Heemskerk; Alastair W Poole
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

8.  RNAi screening for kinases and phosphatases identifies FoxO regulators.

Authors:  Jaakko Mattila; Jukka Kallijärvi; Oscar Puig
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

9.  Podocytic PKC-alpha is regulated in murine and human diabetes and mediates nephrin endocytosis.

Authors:  Irini Tossidou; Beina Teng; Jan Menne; Nelli Shushakova; Joon-Keun Park; Jan U Becker; Friedrich Modde; Michael Leitges; Hermann Haller; Mario Schiffer
Journal:  PLoS One       Date:  2010-04-16       Impact factor: 3.240

Review 10.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.